Transcriptomic study in women with trisomy 21 identifies a possible role of the GTPases of the immunity-associated proteins (GIMAP) in the protection of breast cancer

• DOI: 10.1038/s41598-020-66469-w
• Publication Date: 2020-06-10T10:03:15Z
• Authors: André Mégarbané; David Piquemal; Anne-Sophie Rebillat; Samantha Stora; Fabien Pierrat; Roman Bruno; Florian Noguier; Clotilde Mircher; Aimé Ravel; Marie Vilaire-Meu...; Sophie Durand; Gérard Lefranc
• Keywords: Adult; 0303 health sciences; Science; Gene Expression Profiling; Q; R; Breast Neoplasms; Trisomy; Middle Aged; Article; GTP Phosphohydrolases; 3. Good health; 03 medical and health sciences; GTP-Binding Proteins; Biomarkers, Tumor; Medicine; Humans; Female; France; RNA, Messenger; Down Syndrome; Transcriptome

AbstractBackground: People with trisomy 21 (T21) are predisposed to developing hematological tumors, but have significantly lower-than-expected age-adjusted incidence rates of having a solid tumor. Material and methods: To identify novel genetic factors implicated in the lower breast cancer (BC) frequency observed in women with T21 than in the general population, we compared the transcriptome pattern of women with a homogeneous T21, aged more than 30 years, with or without BC, and tumoral BC tissue of control women with a normal karyotype from the study of Varleyet al. (2014). Results: Differential analysis of gene expression between the 15 women in the T21 without BC group and BC patients in the other groups (two women with T21 and fifteen control women, respectively) revealed 154 differentially expressed genes, of which 63 were found to have similar expression profile (up- or downregulated). Of those 63 genes, four were in the same family, namelyGIMAP4,GIMAP6,GIMAP7andGIMAP8, and were strongly upregulated in the T21 without BC group compared to the other groups. A significant decrease in mRNA levels of these genes in BC tissues compared to non-tumor breast tissues was also noted. Conclusion: We found that the expression of someGIMAPsis significantly higher in women with T21 without BC than in patients with sporadic BC. Our findings support the hypothesis that GIMAPs may play a tumor-suppressive role against BC, and open the possibility that they may also have the same role for other solid tumors in T21 patients. The search for new prognostic factors and hopefully new therapeutic or preventive strategies against BC are discussed.